miconazole has been researched along with fluconazole in 214 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (3.27) | 18.7374 |
| 1990's | 54 (25.23) | 18.2507 |
| 2000's | 63 (29.44) | 29.6817 |
| 2010's | 79 (36.92) | 24.3611 |
| 2020's | 11 (5.14) | 2.80 |
| Authors | Studies |
|---|---|
| Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K | 1 |
| Furuya, K; Lan, LB; Sanglard, D; Schuetz, EG; Schuetz, JD; Yasuda, K | 1 |
| Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK | 1 |
| Artico, M; D'Auria, FD; De Martino, G; Di Pasquali, A; La Regina, G; Nencioni, L; Palamara, AT; Silvestri, R | 1 |
| Chaturvedi, AK; Shukla, PK; Tandon, VK; Yadav, DB | 1 |
| Angiolella, L; Artico, M; Botta, M; Caporuscio, F; Corelli, F; Costi, R; Di Santo, R; Forte, M; Palamara, AT; Tafi, A | 1 |
| Chaturvedi, AK; Shukla, PK; Singh, RV; Tandon, VK; Yadav, DB | 1 |
| Brien, JF; Dercho, RA; Kinobe, RT; Nakatsu, K; Szarek, WA; Vlahakis, JZ | 1 |
| Bergès, T; Bouchara, JP; Chabasse, D; Hennequin, C; Tronchin, G; Vandeputte, P | 1 |
| Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL | 1 |
| Erdoğan, T; Göker, H; Güven, OO; Yildiz, S | 1 |
| Calderone, R; Chauhan, N; Kruppa, M | 1 |
| Bhargava, A; Singh, RK; Srivastava, R | 1 |
| Ebrahimi, SA; Emami, S; Falahati, M; Farahyar, S; Foroumadi, A; Lotfali, E; Rajabalian, S; Shafiee, A | 1 |
| Artico, M; Botta, M; Caporuscio, F; Cirilli, R; D'Auria, FD; De Melo, NR; Kelly, SL; La Regina, G; La Torre, F; Lamb, DC; Nencioni, L; Olla, S; Palamara, AT; Piscitelli, F; Silvestri, R; Tafi, A | 1 |
| Adelson, ME; Chadwick, SG; Gygax, SE; Mordechai, E; Self, MJ; Trama, JP; Vermitsky, JP; Zimmerman, JA | 1 |
| Kelly, DE; Kelly, SL; Manning, NJ; Merkamm, M; Parker, JE; Pompon, D | 1 |
| Bergès, T; Bouchara, JP; Chabasse, D; Ernoult, E; Larcher, G; Tronchin, G; Vandeputte, P | 1 |
| Maurya, HK; Panda, D; ShivaKeshava, GB; Shukla, PK; Srivastava, P; Tandon, VK; Tripathi, A | 1 |
| Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
| Jackson, CJ; Kelly, DE; Kelly, SL; Lamb, DC; Marczylo, TH; Parker, JE; Warrilow, AG | 1 |
| Pratim Roy, P; Roy, K | 1 |
| Maurya, HK; Mishra, NN; Shukla, PK; Tandon, VK | 2 |
| Bergès, T; Bouchara, JP; Chabasse, D; Renier, G; Rocher, F; Tronchin, G; Vandeputte, P | 1 |
| Kaur, J; Komath, SS; Singh, P; Yadav, B | 1 |
| Nagawade, RR; Sangshetti, JN; Shinde, DB | 1 |
| Sangshetti, JN; Shinde, DB | 2 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Inamine, T; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Miyazaki, Y; Nagayoshi, Y; Saijo, T; Seki, M; Yamamoto, Y; Yamauchi, S; Yanagihara, K | 1 |
| Kumar, R; Maurya, HK; Shukla, PK; Tandon, VK; Verma, MK | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Driscoll, MD; Lafite, P; Levy, C; Leys, D; Mast, N; McLean, KJ; Munro, AW; Pikuleva, IA; Rigby, SE | 1 |
| Chabukswar, AR; Sangshetti, JN; Shinde, DB | 1 |
| Komath, SS; Singh, P; Verma, P; Yadav, B | 1 |
| Juvonen, RO; Koskiranta, J; Ollakka, R; Rahnasto-Rilla, M; Raunio, H; Ritvanen, A; Salminen, KA; Tani, N; Wittekindt, C | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ; Teraiya, SB | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ | 1 |
| Ganesh Kumar, C; Poornima, M; Prabhavathi Devi, BL; Prasad, RB; Reddy, TV | 1 |
| Chothe, AS; Dudhe, PB; Gadhwe, S; Kathiravan, MK; Mukta, MS; Salake, AB; Watode, RP | 1 |
| Darandale, SN; Mulla, NA; Pansare, DN; Shinde, DB | 1 |
| Ganesh Kumar, C; Prabhavathi Devi, BL; Prasad, RB; Sujitha, P; Vijai Kumar Reddy, T | 1 |
| Gade, WN; Khan, FA; Marathe, SD; Patil, RH; Sangshetti, JN; Shaikh, RI; Shinde, DB | 1 |
| Mulla, NA; Pansare, DN; Pawar, CD; Shende, VR; Shinde, DB | 1 |
| Mishra, NN; Prabhakar, YS; Saquib, M; Sharma, S; Shaw, AK; Shukla, PK; Srivastava, R; Verma, S | 1 |
| Bardiot, D; Cammue, BP; Chaltin, P; Cos, P; De Brucker, K; Maes, L; Marchand, A; McNaughton, M; Peeters, A; Taborda, CP; Thevissen, K | 1 |
| Akdemir, A; Bizzarri, B; Bolasco, A; Caprara, F; Carradori, S; De Monte, C; Mari, E; Mollica, A; Rivanera, D; Secci, D; Zicari, A | 1 |
| Aktumsek, A; Bizzarri, B; Carradori, S; Chimenti, P; De Monte, C; Mari, E; Mollica, A; Rivanera, D; Secci, D; Zengin, G; Zicari, A | 1 |
| Bahekar, SS; Jawale, CS; Karnik, KS; Pansare, DN; Pawar, CD; Sarkate, AP; Shelke, RN; Shinde, DB | 1 |
| Bizzarri, B; Carradori, S; D'Ascenzio, M; De Monte, C; Grande, R; Mari, E; Patsilinakos, A; Ragno, R; Rivanera, D; Sabatino, M; Secci, D; Zicari, A | 1 |
| Alfatah, M; Arumugam, P; Barkham, T; Brian Chia, CS; Hill, J; Hoon, S; Kong, KW; Lau, QY; Ng, FM; Ng, SMS; Ong, EHQ; Teo, JWP; Yap, JM | 1 |
| Cui, SF; Damu, GLV; Mi, JL; Tangadanchu, VKR; Zhang, Y; Zhou, CH | 1 |
| Dang, LH; Dung, TT; Hai, DS; Kim Van, HT; Ky Duyen, NT; Mai, NT; Ngoc Bich, VT; Thanh Van, TT; Thanh, ND; Thu Hien, PT; Toan, DN; Toan, VN | 1 |
| Zhang, B | 1 |
| Wang, SQ; Wang, YF; Xu, Z | 1 |
| Sun, B; Sun, N; Sun, Y; Tian, L; Zhao, D; Zhao, L; Zhao, S | 1 |
| Benhamou, RI; Dorot, O; Elias, R; Fridman, M; Jaber, QZ; Oved, K; Pichinuk, E; Zada, SL | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| An, R; Guo, C; Guo, MB; Hou, Z; Mou, YH; Su, X; Xu, H | 1 |
| Dinh Thanh, N; Minh Tri, N; Ngoc Toan, V; Thi Thu Huong, N | 1 |
| An, R; Guo, C; Guo, MB; Hou, Z; Mou, YH; Wang, X; Xu, H; Yan, ZZ; Zhang, R | 1 |
| Cheng, M; Su, X; Sun, N; Sun, Y; Tian, L; Yin, W; Zhang, C; Zhao, D; Zhao, L; Zhao, S; Zheng, Y | 1 |
| Bodey, GP | 1 |
| Daujat, M; Domergue, J; Fabre, I; Joyeux, H; Maurel, P; Maurice, M; Pichard, L | 1 |
| Adibzadeh, M; Friccius, H; Pawelec, G; Pohla, H; Schenk, A; Siegels-Hübenthal, P | 1 |
| Anaissie, E; Bodey, G; Gokaslan, A; Griffin, G; Hachem, R; Robinson, R; Rubin, R; Sobel, J | 1 |
| Sotoyama, K | 1 |
| Georgiev, VS | 1 |
| Ehninger, G; Jaschonek, K; Pawelec, G; Rehbein, A; Schaudt, K | 1 |
| Goto, S; Kawasaki, K; Matsumura, Y; Matsunaga, T; Ogawa, M; Tsuji, A | 1 |
| Shindo, K | 1 |
| Bercy, P; De Beule, F; Ferrant, A | 1 |
| Ikemoto, H | 1 |
| Fukuchi, K; Gomi, K; Oguro, T; Sugita, M; Takagi, Y; Tanaka, Y; Wakuta, R | 1 |
| Corbeij, RS; Merkus, HM; Oosterbaan, HP; Stoot, JE; Ubachs, HM; van Heusden, AM; Verhoeff, A | 1 |
| Watanabe, K | 2 |
| Fujita, S; Hisazumi, H; Nishikawa, T; Ohkawa, M; Takashima, M; Tokunaga, S; Wheat, RW | 1 |
| Dupont, B | 1 |
| Blancard, A; Goudard, M; Mary, C; Quilici, M; Regli, P | 1 |
| Walsh, TJ | 1 |
| Pizzo, A; Walsh, TJ | 1 |
| Gordon, MA; Lapa, EW; Passero, PG | 1 |
| Hopwood, V; Johnson, EM; Kennedy, CT; Smith, KJ; Van Cutsem, J; Vanden Bossche, H; Warnock, DW | 1 |
| Beggs, WH; Hughes, CE | 1 |
| Fothergill, AW; McGough, DA; Peter, J; Pizzo, PA; Rinaldi, MG; Walsh, TJ | 1 |
| Hahn, K; Scheven, Ch; Scheven, M; Senf, A | 1 |
| Ahearn, DG; Kalya, AV | 1 |
| Bernhardt, R; Denner, K; Doehmer, J; Schmalix, W; Vogel, R | 1 |
| Maezawa, H; Nakazawa, Y; Saito, A; Sakai, O; Sakamoto, M; Shiba, K; Shindou, N; Yoshida, M; Yoshikawa, K | 1 |
| Buser, U; Egger, T; Gratwohl, A; Passweg, J; Pless, M; Stebler Gysi, C; Tichelli, A; Uhr, M; Wernli, M; Wuhrmann, J | 1 |
| Belcher, KE; Law, EJ; Spencer, SA; Still, JM | 1 |
| Kitamura, S; Shibuya, Y | 1 |
| Genma, H; Imokawa, S; Sato, A; Shirai, T; Sugiura, W; Taniguchi, M | 1 |
| Ancarani, F; Arzeni, D; Barchiesi, F; Del Poeta, M; Marinucci, G; Morbiducci, V; Scalise, G | 1 |
| Chubachi, A; Miura, AB; Miura, I; Niitsu, H; Nimura, T; Nishinari, T; Ohshima, A | 1 |
| Bartlett, MS; Queener, SF; Richardson, JD; Shaw, MM; Smith, JW | 1 |
| Chubachi, A; Miura, AB; Miura, I; Niitsu, H; Nimura, T; Ohshima, A | 1 |
| Fukai, Y; Kashiwabara, K; Nakamura, H; Semba, H | 1 |
| Horikami, H; Ishii, K; Iwasaki, M; Izai, K; Kazami, N; Nakagawa, H; Shirasaka, R; Uchida, Y; Yamaura, H | 1 |
| Horimoto, M; Hyodo, T; Kase, M; Yokoi, M | 1 |
| Antonacci, B; Cacciapuoti, A; Hare, RS; Loebenberg, D; Menzel, F; Miller, GH; Moss, L; Norris, C; Parmegiani, RM; Yarosh-Tomaine, T | 1 |
| Kaku, M; Koga, H; Kohno, S; Maesaki, S; Yamada, H | 1 |
| Bedrossian, J; Ben Hamida, M; Fouqueray, B; Idatte, JM; Metivier, F; Pruna, A | 1 |
| Drummond, DC; McCormack, JG; Whitman, LM; Wong, CW | 1 |
| Catalin, J; Durand, A; Lacarelle, B; Rajaonarison, JF; Sampol, E | 1 |
| Oikarinen, KS; Raustia, AM; Salonen, MA | 1 |
| Kume, H; Murase, S | 1 |
| Fujita, S | 1 |
| Goto, Y; Hashimoto, A; Nagai, H; Nasu, M; Perparim, K; Tashiro, T | 1 |
| Acosta, D; Rodriguez, RJ | 1 |
| Igari, J; Yamane, N | 1 |
| Gøtzsche, PC; Johansen, HK | 1 |
| Carver, PL; Kauffman, CA | 1 |
| Adeyemi-Doro, FA; Chan, RC; Cheng, AF; Cheung, SW; Ng, TK | 1 |
| Yamaguchi, H | 1 |
| Asari, S; Endo, T; Shimomura, Y; Tahara, K; Yanagihara, T | 1 |
| Cihlar, RL; McElhaney-Feser, GE; Raulli, RE | 1 |
| Fujihara, M; Kyo, T; Mikami, Y; Myoken, Y; Sugata, T | 1 |
| Benko, I; Hernádi, F; Kiss, A; Kovács, P; Kraicsovits, F; Megyeri, A; Somogyi, G; Tegyey, Z | 1 |
| Bouchara, JP; Chabasse, D; Declerk, P; Defontaine, A; Hallet, JN; Planchenault, C | 1 |
| Desmet, P; Raes-Wuytack, C; Swinne, D; Van Looveren, K | 1 |
| Ebihara, M; Hosoya, J; Nakagawa, Y; Ojima, F; Shoji, T; Toyoguchi, T | 1 |
| Iga, T; Kawakami, J; Sato, H; Sawamura, R | 1 |
| Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, M; Seibold, M; Willinger, B | 1 |
| Haapasalo, MP; Meurman, JH; Samaranayake, LP; Waltimo, TM; Ørstavik, D | 1 |
| Ellepola, AN; Samaranayake, LP | 2 |
| Buslaeva, GN | 1 |
| Bruserud, O | 1 |
| De Bruin, ML; Herings, RM; Hoes, AW; Leufkens, HG; Panneman, MJ | 1 |
| Boyd, DH; Cannon, RD; Girgis, JM; Holmes, AR; Niimi, M | 1 |
| Bauters, TG; Moerman, M; Nelis, HJ; Vermeersch, H | 1 |
| Engelen, M; Rochette, F; Vanden Bossche, H | 1 |
| Dabbs, ER; Lephoto, C; Naidoo, S; Nikitina, N | 1 |
| Kamei, K | 1 |
| Beaudry, V; Cunningham, K; Gupta, SS; Rao, R; Rulli, S; Ton, VK | 1 |
| Mazneĭkova, V | 1 |
| Gangneux, JP; Guiguen, C; Preney, L; Théraud, M | 1 |
| Lamfon, H; McCullough, M; Porter, SR; Pratten, J | 1 |
| Austin, NC; Darlow, B | 1 |
| Arai, M; Fukuda, T; Masuma, R; Omura, S; Tomoda, H; Yamaguchi, Y | 1 |
| Dhaliwal, HS; Oliver, RJ; Pemberton, MN; Theaker, ED | 1 |
| Carrillo-Muñoz, AJ; Casals, J; del Valle, O; Guardià, C; Guglietta, A; Palacín, C; Quindós, G; Rodríguez, V | 1 |
| Kamatani, T; Osaki, T; Ueta, E; Yamamoto, T | 1 |
| Niwa, T; Shiraga, T; Takagi, A | 1 |
| Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW | 1 |
| Brouwer, N; Jamie, J; Kohen, J; Vemulpad, S | 1 |
| Nakamura, K; Nakasone, I; Ohta, C; Onaga, S; Yamane, N | 1 |
| Fukushima, K; Hyon, SH; Park, BJ; Park, JC; Taguchi, H; Takatori, K | 1 |
| Blignaut, E; Botes, ME; Nieman, HL | 1 |
| Abe, S; Uchida, K; Yamaguchi, H | 1 |
| Malecha, MA; Malecha, MJ; Tarigopula, S | 1 |
| Babu, KS; Clark, AM; Ferreira, D; Jacob, MR; Khan, SI; Li, XC; Zhang, Q | 1 |
| de Assis Santos, D; Figueiredo, VT; Hamdan, JS; Resende, MA | 1 |
| Brown, HS; Chadwick, A; Houston, JB | 1 |
| Perheentupa, J; Pfaller, M; Rautemaa, R; Richardson, M; Saxen, H | 1 |
| Ambudkar, SV; Gaur, M; Prasad, R; Puri, N; Sharma, M; Shukla, S | 1 |
| Ambudkar, SV; Manoharlal, R; Prasad, R; Prasad, T; Puri, N; Sharma, M; Shukla, S | 1 |
| Ghannoum, MA; Isham, N | 1 |
| Austin, N; Darlow, BA; McGuire, W | 2 |
| Fick, J; Lindberg, RH; Tysklind, M | 1 |
| Kelly, DE; Kelly, SL; Lamb, DC; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG | 1 |
| Heeres, J; Lewi, P; Meerpoel, L | 1 |
| Calahorra, M; Lozano, C; Peña, A; Sánchez, NS | 1 |
| Arita, Y; Boone, C; Matsuyama, A; Nishimura, S; Usui, T; Yashiroda, Y; Yoshida, M | 1 |
| Prasad, R; Sharma, M | 1 |
| Cafarchia, C; Figueredo, LA; Iatta, R; Montagna, MT; Otranto, D | 1 |
| Katayama, N; Kohara, T; Kyo, T; Nakase, K; Sugawara, Y; Suzuki, K | 1 |
| Huang, Q; Peng, X; Wang, C; Wang, Z; Yu, Y; Zhang, K | 1 |
| Macura, AB; Skóra, M | 1 |
| An, G; Choi, JY; Choi, TH; Han, SJ; Jeon, TJ; Kim, BS; Kim, CH; Kim, DG; Kim, JY; Kim, KM; Lee, KC; Lee, M; Ryu, YH; Seo, YB; Woo, KS; Yi, CH; Yi, DI | 1 |
| Apratim, A; Chopde, N; Khade, MN; Khadtare, YR; Pharande, A; Shah, SS | 1 |
| Furuya, N; Mano, Y; Morishige, H; Oguri, T | 1 |
| Czaika, VA; Lam, PA | 1 |
| Coleman, K; Dahl, T; Ghannoum, M; Keating, J; Lafleur, MD; Lee, RE; Lewis, K; Lister, I; Long, L; Nantel, A; North, J; Sun, L | 1 |
| Monod, M; Pot, SA; Spiess, BM; Unger, L; Voelter-Ratson, K | 1 |
| Almutairi, MS; Attia, MI; Ghoneim, SW; Zakaria, AS | 1 |
| Fujisaki, J; Hamada, T; Hirabayashi, D; Kamikawa, Y; Mori, Y; Nagayama, T; Sakamoto, R; Sugihara, K | 1 |
| Fan, S; Li, J; Liu, X; Shan, Y; Zhu, Y | 1 |
| Bax, M; Cammue, BP; Cools, TL; Cos, P; De Brucker, K; De Cremer, K; Lanckacker, E; Thevissen, K | 1 |
| Buffon, R; Manzoor, S; Rossi, AV | 1 |
| Lewis, M | 1 |
| Fan, S; Liang, Y; Liu, X | 1 |
| Abu-Hammad, OA; Al-Omiri, MK; Al-Shayyab, MH; Dar-Odeh, NS | 1 |
| Desai, MM; Frenkel, EM; Kosheleva, K; Lang, GI; McDonald, MJ; Van Dyken, JD | 1 |
| Ling, J; Ning, Y; Wu, CD | 1 |
| Khedr, MA | 1 |
| Akiyama, K; Kakinuma, Y; Kawahara, R; Kawano-Kawada, M; Pongcharoen, P; Sekito, T; Yamasaki, T; Yasuda, M | 1 |
| Ahmad, N; Hashim, R; Khairam, H; Mohd Fuat, AR; Mohd Tap, R; Ng, PP; Ramli, NY; Sabaratnam, P | 1 |
| Austin, N; Cleminson, J; Darlow, BA; McGuire, W | 1 |
| Bai, HH; Dong, HY; Liu, ZH; Wang, FJ; Wu, WX; Zhang, D | 1 |
| Alegre, LR; Carrillo-Muñoz, AJ; Cattana, ME; Córdoba, SB; de Los Ángeles Sosa, M; Fernández, MS; Giusiano, GE; Rojas, FD; Zalazar, LC | 1 |
| Barkham, T; Cheong, JW; Chia, CS; Hill, J; Lau, QY; Ng, FM; Ng, SM; Teo, JW; Yap, YY | 1 |
| Dhital, S; Kattel, HP; Khadka, S; Khatiwada, S; Mishra, SK; Parajuli, K; Parajuli, N; Pokhrel, BM; Pradhan, M; Rijal, BP; Shah, N; Sharma, S; Sherchand, JB | 1 |
| Al Rawashdah, S; Atatreh, N; Bryce, RA; Ghattas, MA; Zalloum, WA | 1 |
| Chen, H; Fang, F; Feng, D; Mei, L; Wang, X; Wei, DM; Xie, HY | 1 |
| de Abajo, FJ; Gaist, D; Martín-Pérez, M; Rodríguez, LAG | 1 |
| Spitzer, M; Wiederhold, NP | 1 |
| Alves, SH; de Jesus, FPK; Farias, JB; Ferreiro, L; Loreto, ES; Santurio, JM; Schlemmer, KB | 1 |
| Eraso, E; Gil-Alonso, S; Jauregizar, N; Marcos-Arias, C; Mateo, E; Quindós, G; Sevillano, E | 1 |
| Hay, RJ; Jemec, GBE; Saunte, DML; Taudorf, EH | 1 |
| Elgaard, C; Kretschmann, AC; Munkboel, CH; Olesen, MK; Rasmussen, TB; Styrishave, B | 1 |
| Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
| Aabenhus, RM; Hellfritzsch, M; Iversen, DB; Lind, BS; Pottegård, A; Stage, TB | 1 |
| Lee, A; Saeed, SR; Tysome, JR | 1 |
| Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A | 1 |
| Benedetti, MD; Braga, SFP; Caldas, IS; Campos Péret, VA; Carvalho, DT; Johann, S; Reis, RCFM; Santana, LFA; Souza, TB | 1 |
| Čonková, E; Malinovská, Z; Váczi, P | 1 |
| Hu, Q; Li, T; Liu, N; Liu, Q; Peng, Y; Yang, J | 1 |
31 review(s) available for miconazole and fluconazole
| Article | Year |
|---|---|
The biology and chemistry of antifungal agents: a review.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Imidazoles; Mycoses | 2012 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Tetrazole hybrids and their antifungal activities.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles | 2019 |
Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research.
Topics: Animals; Binding Sites; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Development; Heme; Humans; Hydrophobic and Hydrophilic Interactions; Protein Binding | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Azole antifungal agents.
Topics: Animals; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses | 1992 |
Treatment and developmental therapeutics in aspergillosis. 2. Azoles and other antifungal drugs.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Azoles; Clotrimazole; Disease Models, Animal; Fluconazole; Humans; Imidazoles; Ketoconazole; Lung Diseases, Fungal; Miconazole; Otitis Externa | 1992 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1987 |
Treatment of systemic fungal infections: recent progress and current problems.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1988 |
[Antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Miconazole | 1995 |
Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic | 1997 |
Use of azoles for systemic antifungal therapy.
Topics: Antifungal Agents; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1997 |
[Antimicrobial drug therapy and microbial sensitivity tests--antifungal agents and microbial sensitivity tests].
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Miconazole; Microbial Sensitivity Tests; Quality Control; Saccharomyces cerevisiae | 1997 |
[Advances in the treatment of severe refractory infections. 4) Deep fungal infection].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Miconazole; Mycoses | 1998 |
Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Clotrimazole; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Nystatin; Virulence | 2000 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs | 2003 |
[Present status and future prospects of azole antifungal agents in Japan].
Topics: Antifungal Agents; Azoles; Cyclodextrins; Drug Design; Fluconazole; Forecasting; Itraconazole; Japan; Miconazole; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
[Vaginal candidiasis--treatment protocols using miconazole and fluconazole].
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Diagnosis, Differential; Female; Fluconazole; Humans; Miconazole | 2003 |
Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Miconazole; Nystatin; Randomized Controlled Trials as Topic | 2004 |
[Drug-drug interaction of antifungal drugs].
Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microsomes, Liver; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Miconazole; Nystatin; Randomized Controlled Trials as Topic | 2009 |
Conazoles.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole | 2010 |
Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Miconazole; Mycoses; Nystatin; Randomized Controlled Trials as Topic | 2013 |
Subcutaneous Infection Associated with Trichosporon ovoides: A Case Report and Review of Literature.
Topics: Antifungal Agents; Dermatomycoses; DNA, Intergenic; Female; Fluconazole; Humans; Immunocompromised Host; Miconazole; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Polymerase Chain Reaction; Trichosporon; Trichosporonosis | 2016 |
Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Miconazole; Mycoses; Nystatin; Randomized Controlled Trials as Topic | 2015 |
Probiotics for vulvovaginal candidiasis in non-pregnant women.
Topics: Administration, Intravaginal; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fluconazole; Humans; Imidazoles; Miconazole; Probiotics; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention | 2017 |
Therapeutic tools for oral candidiasis: Current and new antifungal drugs.
Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis, Oral; Caspofungin; Clotrimazole; Databases, Factual; Drug Interactions; Echinocandins; Fluconazole; Humans; Miconazole; Nitriles; Nystatin; Pyridines; Triazoles | 2019 |
Cutaneous candidiasis - an evidence-based review of topical and systemic treatments to inform clinical practice.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Cutaneous; Clotrimazole; Drug Therapy, Combination; Evidence-Based Medicine; Fluconazole; Humans; Ketoconazole; Miconazole; Nystatin | 2019 |
Topical azole treatments for otomycosis.
Topics: Administration, Topical; Adult; Antifungal Agents; Bias; Child; Clotrimazole; Cycloheptanes; Fluconazole; Humans; Imidazoles; Miconazole; Otomycosis; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Efficacy of photodynamic therapy in the treatment of oral candidiasis: a systematic review and meta-analysis.
Topics: Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Miconazole; Nystatin; Photochemotherapy | 2023 |
5 trial(s) available for miconazole and fluconazole
| Article | Year |
|---|---|
Single-dose oral fluconazole versus single-dose topical miconazole for the treatment of acute vulvovaginal candidosis.
Topics: Acute Disease; Administration, Intravaginal; Administration, Oral; Adult; Candidiasis, Vulvovaginal; Consumer Behavior; Double-Blind Method; Female; Fluconazole; Humans; Miconazole; Middle Aged | 1990 |
Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients. A prospective, randomized, single-center study.
Topics: Adolescent; Adult; Aged; Female; Fluconazole; Humans; Immunocompromised Host; Male; Miconazole; Middle Aged; Mycoses; Neutropenia; Nystatin; Prospective Studies | 1995 |
[Usefulness of percutaneous instillation of antifungal agents for pulmonary aspergilloma].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Female; Fluconazole; Humans; Instillation, Drug; Lung Diseases, Fungal; Male; Miconazole; Middle Aged | 1995 |
Effect of treatment of palatal inflammatory papillary hyperplasia with local and systemic antifungal agents accompanied by renewal of complete dentures.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Chi-Square Distribution; Denture, Complete, Upper; Female; Fluconazole; Humans; Hyperplasia; Male; Miconazole; Middle Aged; Mouth Mucosa; Palate; Stomatitis, Denture; Treatment Outcome | 1996 |
Miconazole nitrate vaginal suppository 1,200 mg versus oral fluconazole 150 mg in treating severe vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Case-Control Studies; Female; Fluconazole; Follow-Up Studies; Humans; Miconazole; Middle Aged; Suppositories; Treatment Outcome; Young Adult | 2015 |
178 other study(ies) available for miconazole and fluconazole
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine | 2002 |
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine | 2002 |
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship | 2003 |
Imidazole analogues of fluoxetine, a novel class of anti-Candida agents.
Topics: Antifungal Agents; Candida albicans; Cell Line, Tumor; Cell Survival; Fluoxetine; Humans; Imidazoles; Microbial Sensitivity Tests; Structure-Activity Relationship | 2004 |
Synthesis of (1,4)-naphthoquinono-[3,2-c]-1H-pyrazoles and their (1,4)-naphthohydroquinone derivatives as antifungal, antibacterial, and anticancer agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Candida albicans; Carcinoma 256, Walker; Cryptococcus neoformans; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Naphthoquinones; Pyrazoles; Rats; Structure-Activity Relationship | 2005 |
Antifungal agents. 11. N-substituted derivatives of 1-[(aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: synthesis, anti-Candida activity, and QSAR studies.
Topics: Antifungal Agents; Candida albicans; Imidazoles; Microbial Sensitivity Tests; Models, Molecular; Pyrroles; Quantitative Structure-Activity Relationship | 2005 |
Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.
Topics: Amino Acids; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Methyl Ethers; Molecular Structure; Naphthoquinones | 2005 |
Inhibition of the enzymatic activity of heme oxygenases by azole-based antifungal drugs.
Topics: Animals; Antifungal Agents; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Ketoconazole; Kinetics; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley | 2006 |
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementation Test; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phenotype; Polyenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; RNA, Messenger; Sterols | 2007 |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase | 2007 |
Synthesis and antimicrobial activity of some novel phenyl and benzimidazole substituted benzyl ethers.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Benzimidazoles; Benzyl Compounds; Drug Resistance, Bacterial; Ethers; Methicillin; Microbial Sensitivity Tests; Phenols; Staphylococcus aureus | 2007 |
The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole.
Topics: Antifungal Agents; Candida albicans; Culture Media; Drug Resistance, Fungal; Fluconazole; Histidine Kinase; Microbial Sensitivity Tests; Mutation; Phenotype; Phosphorylation; Protein Kinases; Pyrimidines; Signal Transduction; Triazoles; Voriconazole | 2007 |
Synthesis and antimicrobial activity of some novel nucleoside analogues of adenosine and 1,3-dideazaadenosine.
Topics: Adenosine; Anti-Infective Agents; Bacteria; Fungi; Microbial Sensitivity Tests; Molecular Structure; Tubercidin | 2007 |
2-Hydroxyphenacyl azoles and related azolium derivatives as antifungal agents.
Topics: Acetophenones; Antifungal Agents; Azoles; Microbial Sensitivity Tests; Structure-Activity Relationship | 2008 |
1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
Topics: Antifungal Agents; Arthrodermataceae; Candida albicans; Cell Line, Tumor; Cell Survival; Computer Simulation; Humans; Imidazoles; Models, Molecular; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 2008 |
Antifungal resistance of Candida glabrata vaginal isolates and development of a quantitative reverse transcription-PCR-based azole susceptibility assay.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Up-Regulation; Vagina | 2008 |
Differential azole antifungal efficacies contrasted using a Saccharomyces cerevisiae strain humanized for sterol 14 alpha-demethylase at the homologous locus.
Topics: Antifungal Agents; Azoles; Base Sequence; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Genes, Fungal; Humans; Molecular Sequence Data; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Species Specificity; Sterol 14-Demethylase | 2008 |
A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata.
Topics: Antifungal Agents; Azoles; Base Sequence; Candida glabrata; Candidiasis; Codon, Nonsense; DNA, Fungal; Drug Resistance, Fungal; Ergosterol; Genes, Fungal; Guanine; Humans; Molecular Sequence Data; Polyenes | 2008 |
2,3-Disubstituted-1,4-naphthoquinones, 12H-benzo[b]phenothiazine-6,11-diones and related compounds: synthesis and biological evaluation as potential antiproliferative and antifungal agents.
Topics: Antifungal Agents; Antineoplastic Agents; Cell Proliferation; HeLa Cells; Humans; Hydroquinones; Phenothiazines; Sporothrix; Structure-Activity Relationship | 2009 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
Identification, characterization, and azole-binding properties of Mycobacterium smegmatis CYP164A2, a homolog of ML2088, the sole cytochrome P450 gene of Mycobacterium leprae.
Topics: Amino Acid Motifs; Amino Acid Sequence; Azoles; Base Sequence; Cloning, Molecular; Conserved Sequence; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Genes, Bacterial; Hydrogen-Ion Concentration; Molecular Sequence Data; Molecular Structure; Molecular Weight; Mycobacterium leprae; Mycobacterium smegmatis; Osmolar Concentration; Recombinant Proteins; Sequence Homology, Amino Acid; Sodium Chloride | 2009 |
Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Topics: Algorithms; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Factor Analysis, Statistical; Least-Squares Analysis; Linear Models; Models, Molecular; Neural Networks, Computer; Quantitative Structure-Activity Relationship; Reproducibility of Results | 2009 |
Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Drug Design; Fungi; Microbial Sensitivity Tests; Naphthoquinones; Nitrogen; Sulfur | 2009 |
Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth.
Topics: Adult; Aerobiosis; Antifungal Agents; Azoles; Candida glabrata; Chromatography, High Pressure Liquid; Ergosterol; Female; Flow Cytometry; Genes, Fungal; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Molecular Sequence Data; Polyenes | 2009 |
Design, synthesis and evaluations of acridone derivatives using Candida albicans--search for MDR modulators led to the identification of an anti-candidiasis agent.
Topics: Acridines; Acridones; Antifungal Agents; Candida albicans; Drug Design; Drug Resistance, Multiple, Fungal; Microbial Sensitivity Tests; Molecular Structure; Piperidines | 2009 |
Synthesis of novel 3-(1-(1-substituted piperidin-4-yl)-1H-1,2,3-triazol-4-yl)-1,2,4-oxadiazol-5(4H)-one as antifungal agents.
Topics: Antifungal Agents; Fluconazole; Miconazole; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Triazoles | 2009 |
One pot synthesis and SAR of some novel 3-substituted 5,6-diphenyl-1,2,4-triazines as antifungal agents.
Topics: Antifungal Agents; Catalysis; Fluconazole; Miconazole; Microbial Sensitivity Tests; Piperidines; Structure-Activity Relationship; Triazines; Zirconium | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
Topics: Animals; Antifungal Agents; Base Sequence; Calcineurin; Candida glabrata; Candidiasis; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Female; Fungal Proteins; Genes, Fungal; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation; Opportunistic Infections; Transcription Factors; Virulence | 2010 |
'On water' assisted synthesis and biological evaluation of nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Green Chemistry Technology; Microbial Sensitivity Tests; Naphthoquinones; Nitrogen; Sulfur; Water | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.
Topics: Cholesterol; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Host-Pathogen Interactions; Humans; Hydroxylation; Mycobacterium tuberculosis; Oxidation-Reduction; Protein Structure, Tertiary | 2010 |
Microwave assisted one pot synthesis of some novel 2,5-disubstituted 1,3,4-oxadiazoles as antifungal agents.
Topics: Antifungal Agents; Candida albicans; Catalysis; Fluconazole; Fusarium; Miconazole; Microbial Sensitivity Tests; Microwaves; Oxadiazoles; Structure-Activity Relationship; Sulfites | 2011 |
Synthesis of some novel 3-(1-(1-substitutedpiperidin-4-yl)-1H-1,2,3-triazol-4-yl)-5-substituted phenyl-1,2,4-oxadiazoles as antifungal agents.
Topics: Antifungal Agents; Benzoates; Carbonates; Fungi; Imidazoles; Microbial Sensitivity Tests; Oxadiazoles; Potassium; Structure-Activity Relationship; Triazoles | 2011 |
Synthesis and evaluation of indole-based new scaffolds for antimicrobial activities--identification of promising candidates.
Topics: Anti-Infective Agents; Catalytic Domain; DNA Topoisomerases, Type II; Escherichia coli; Indoles; Inhibitory Concentration 50; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Sterol 14-Demethylase; Tetrahydrofolate Dehydrogenase | 2011 |
Micelles catalyzed chemoselective synthesis 'in water' and biological evaluation of oxygen containing hetero-1,4-naphthoquinones as potential antifungal agents.
Topics: Antifungal Agents; Candida; Catalysis; Drug Evaluation, Preclinical; Micelles; Microbial Sensitivity Tests; Naphthoquinones; Oxygen; Sporothrix; Trichophyton; Water | 2011 |
Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans.
Topics: Antifungal Agents; Candida albicans; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Liver; Models, Molecular; Nitriles; Protein Conformation; Saccharomyces cerevisiae; Sterol 14-Demethylase; User-Computer Interface | 2012 |
An efficient one-pot synthesis, structure, antimicrobial and antioxidant investigations of some novel quinolyldibenzo[b,e][1,4]diazepinones.
Topics: Anti-Infective Agents; Antioxidants; Azepines; Crystallography, X-Ray; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Conformation; Quinolines | 2012 |
An improved microwave assisted one-pot synthesis, and biological investigations of some novel aryldiazenyl chromeno fused pyrrolidines.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Azo Compounds; Benzopyrans; Candida albicans; Crystallography, X-Ray; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Stereoisomerism; Thiosemicarbazones | 2012 |
Total synthesis and antifungal activity of (2S,3R)-2-aminododecan-3-ol.
Topics: Antifungal Agents; Candida; Dodecanol; Molecular Structure | 2012 |
Green synthesis of tetrahydropyrimidine analogues and evaluation of their antimicrobial activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Aspergillus; Bacillus subtilis; Candida albicans; Catalysis; Escherichia coli; Green Chemistry Technology; Microbial Sensitivity Tests; Pyrimidines; Staphylococcus aureus; Zirconium | 2013 |
Total synthesis and biological evaluation of clavaminol-G and its analogs.
Topics: Acetamides; Alkanes; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fungi; HeLa Cells; Humans; MCF-7 Cells; Molecular Structure; Structure-Activity Relationship | 2013 |
Synthesis, antileishmanial activity and docking study of N'-substitutedbenzylidene-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetohydrazides.
Topics: Administration, Oral; Anti-Infective Agents; Antiprotozoal Agents; Benzylidene Compounds; Binding Sites; Drug Design; Half-Life; Hydrazines; Leishmania donovani; Microbial Sensitivity Tests; Molecular Docking Simulation; Oxidoreductases; Protein Structure, Tertiary; Protozoan Proteins; Pyridines | 2014 |
One pot three components microwave assisted and conventional synthesis of new 3-(4-chloro-2-hydroxyphenyl)-2-(substituted) thiazolidin-4-one as antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus flavus; Aspergillus niger; Candida albicans; Dose-Response Relationship, Drug; HeLa Cells; Humans; MCF-7 Cells; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Thiazolidines | 2014 |
Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Carbohydrates; Catalytic Domain; Cell Line; Chemistry Techniques, Synthetic; Click Chemistry; Drug Design; Fungi; Microbial Sensitivity Tests; Models, Molecular; Penicillin-Binding Proteins; Triazoles | 2014 |
2-(2-oxo-morpholin-3-yl)-acetamide derivatives as broad-spectrum antifungal agents.
Topics: Acetamides; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Morpholines; Species Specificity; Structure-Activity Relationship; Substrate Specificity | 2015 |
Anti-Candida activity and cytotoxicity of a large library of new N-substituted-1,3-thiazolidin-4-one derivatives.
Topics: 14-alpha Demethylase Inhibitors; Anti-Bacterial Agents; Antifungal Agents; Candida; Chemistry Techniques, Synthetic; Drug Design; Drug Evaluation, Preclinical; Fungal Proteins; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Small Molecule Libraries; Sterol 14-Demethylase; Structure-Activity Relationship; Thiazolidines | 2016 |
Novel 1,3-thiazolidin-4-one derivatives as promising anti-Candida agents endowed with anti-oxidant and chelating properties.
Topics: Antifungal Agents; Antioxidants; Candida; Chelating Agents; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Thiazolidines; Toxicity Tests | 2016 |
Synthesis and antimicrobial evaluation of novel ethyl 2-(2-(4-substituted)acetamido)-4-subtituted-thiazole-5-carboxylate derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus flavus; Aspergillus niger; Bacillus subtilis; Candida albicans; Carboxylic Acids; Dose-Response Relationship, Drug; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles | 2016 |
Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity.
Topics: Antifungal Agents; Candida; Carbon-13 Magnetic Resonance Spectroscopy; Drug Screening Assays, Antitumor; Gram-Negative Bacteria; Gram-Positive Bacteria; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Quantitative Structure-Activity Relationship; Thiazolidines | 2017 |
Structure-activity relationship studies of ultra-short peptides with potent activities against fluconazole-resistant Candida albicans.
Topics: Antifungal Agents; Candida albicans; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fibroblasts; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Structure; Peptides; Structure-Activity Relationship | 2018 |
Discovery of potential antifungal triazoles: design, synthesis, biological evaluation, and preliminary antifungal mechanism exploration.
Topics: | 2017 |
Efficient click chemistry towards novel 1H-1,2,3-triazole-tethered 4H-chromene-d-glucose conjugates: Design, synthesis and evaluation of in vitro antibacterial, MRSA and antifungal activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzopyrans; Click Chemistry; Drug Design; Fungi; Glucose; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Triazoles | 2019 |
Antifungal activity, mode of action variability, and subcellular distribution of coumarin-based antifungal azoles.
Topics: Antifungal Agents; Azoles; Candida; Cell Survival; Coumarins; Dose-Response Relationship, Drug; HEK293 Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Optical Imaging; Structure-Activity Relationship | 2019 |
Design, synthesis, and biological evaluation of novel miconazole analogues containing selenium as potent antifungal agents.
Topics: Antifungal Agents; Biofilms; Drug Design; Drug Resistance, Multiple, Fungal; Fluconazole; Fungi; Humans; Miconazole; Microbial Sensitivity Tests; Molecular Docking Simulation; Organoselenium Compounds; Structure-Activity Relationship | 2020 |
Synthesis and biological screening of thiosemicarbazones of substituted 3-acetylcoumarins having d-glucose moiety.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Coumarins; Fungi; Glucose; Humans; Microbial Sensitivity Tests; Mycoses; Structure-Activity Relationship; Thiosemicarbazones | 2020 |
Lead optimization generates selenium-containing miconazole CYP51 inhibitors with improved pharmacological profile for the treatment of fungal infections.
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Binding Sites; Biofilms; Candida; Candidiasis; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Design; Half-Life; Humans; Mice; Miconazole; Microbial Sensitivity Tests; Molecular Docking Simulation; Selenium; Sterol 14-Demethylase; Structure-Activity Relationship | 2021 |
Improving the metabolic stability of antifungal compounds based on a scaffold hopping strategy: Design, synthesis, and structure-activity relationship studies of dihydrooxazole derivatives.
Topics: Antifungal Agents; Drug Design; Humans; Molecular Structure; Structure-Activity Relationship | 2021 |
Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture.
Topics: Blotting, Northern; Cells, Cultured; Clotrimazole; Cytochrome P-450 Enzyme System; Fluconazole; Humans; Imidazoles; Kinetics; Liver; Metronidazole; Miconazole; Microsomes, Liver; Mixed Function Oxygenases; RNA; RNA, Messenger | 1992 |
The effects of the antifungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells.
Topics: Antifungal Agents; Cells, Cultured; Cyclosporine; Cytokines; Fluconazole; Gene Expression; Humans; Itraconazole; Ketoconazole; Lymphocytes; Miconazole; Tacrolimus | 1992 |
Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review.
Topics: Adult; Aged; Amphotericin B; Animals; Antifungal Agents; Child, Preschool; Disease Models, Animal; Female; Fluconazole; Humans; Immunocompromised Host; Male; Mice; Miconazole; Middle Aged; Mycoses; Triazoles; Trichosporon | 1992 |
[Countermeasure for infections with granulocytopenia].
Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Candidiasis; Cephalosporins; Drug Therapy, Combination; Fluconazole; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Miconazole; Pneumonia; Recombinant Proteins; Risk Factors; Sepsis | 1992 |
Comparison of the immunosuppressive activities of the antimycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cells.
Topics: Antifungal Agents; Cytokines; Fluconazole; Humans; Immunosuppressive Agents; In Vitro Techniques; Interleukin-2; Itraconazole; Ketoconazole; Lymphocyte Activation; Miconazole; T-Lymphocytes | 1991 |
[In vivo and in vitro antifungal activity of fluconazole].
Topics: Animals; Aspergillus; Candida albicans; Candidiasis; Cryptococcus; Drug Resistance, Microbial; Fluconazole; Ketoconazole; Male; Mice; Mice, Inbred ICR; Miconazole | 1991 |
Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis; Miconazole; Middle Aged | 1990 |
The effectiveness of a preventive regimen on the periodontal health of patients undergoing chemotherapy for leukemia and lymphoma.
Topics: Acyclovir; Amphotericin B; Ceftazidime; Chlorhexidine; Dental Plaque Index; Fluconazole; Humans; Immunosuppression Therapy; Ketoconazole; Leukemia; Lymphoma; Miconazole; Norfloxacin; Periodontal Diseases; Periodontal Index; Tooth Loss; Vancomycin | 1991 |
[Drug therapy of intractable mycoses].
Topics: Administration, Oral; Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Flucytosine; Humans; Infusions, Intravenous; Lung Diseases, Fungal; Miconazole; Mycoses | 1990 |
[Identification and susceptibility of clinically isolated yeast-like fungi].
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Humans; Miconazole; Microbial Sensitivity Tests; Yeasts | 1990 |
[Antifungal agents].
Topics: Administration, Oral; Amphotericin B; Fluconazole; Flucytosine; Humans; Infusions, Intravenous; Injections, Intraventricular; Injections, Spinal; Miconazole; Mycoses | 1990 |
In vitro susceptibility testing of Candida isolates from clinical specimens to four antifungal agents.
Topics: Amphotericin B; Candida; Drug Evaluation; Fluconazole; Flucytosine; Miconazole; Microbial Sensitivity Tests; Species Specificity | 1990 |
[Treatment of mycoses and new antifungal agents].
Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 1989 |
[Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Flucytosine; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Yeasts | 1989 |
Improved method for azole antifungal susceptibility testing.
Topics: Antifungal Agents; Azoles; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Triazoles | 1988 |
Azole resistance in Candida albicans.
Topics: Adult; Animals; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous; Disease Models, Animal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Guinea Pigs; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Mice; Miconazole; Rats; Rats, Inbred Strains; Triazoles | 1986 |
Action of fluconazole (UK-49,858) in relation to other systemic antifungal azoles.
Topics: Antifungal Agents; Candida; Candida albicans; Fluconazole; Ketoconazole; Miconazole; Triazoles | 1987 |
Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.
Topics: Amphotericin B; Antifungal Agents; Azoles; Drug Therapy, Combination; Fluconazole; Itraconazole; Miconazole; Microbial Sensitivity Tests; Pseudallescheria | 1995 |
[Post-antibiotic effect and post-exposure polyene antagonism of azole antimycotics in Candida albicans: dependency on lipophilia].
Topics: Amphotericin B; Candida albicans; Drug Interactions; Fluconazole; Itraconazole; Ketoconazole; Lipids; Miconazole; Microbial Sensitivity Tests; Structure-Activity Relationship | 1995 |
Increased resistance to antifungal antibiotics of Candida spp. adhered to silicone.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Cell Adhesion; Drug Resistance, Microbial; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Silicones; Urinary Catheterization | 1995 |
Cloning and stable expression of the human mitochondrial cytochrome P45011B1 cDNA in V79 Chinese hamster cells and their application for testing of potential inhibitors.
Topics: Adrenal Glands; Animals; Base Sequence; Cell Line; Cloning, Molecular; Clotrimazole; Cricetinae; Cricetulus; DNA Primers; DNA, Complementary; Fluconazole; Gene Expression; Hydrocortisone; Hydroxylation; Ketoconazole; Kinetics; Metyrapone; Miconazole; Mitochondria; Molecular Sequence Data; Polymerase Chain Reaction; Recombinant Proteins; Restriction Mapping; Spironolactone; Steroid 11-beta-Hydroxylase; Transfection | 1995 |
[Treatment of severe pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) and Candida krusei with granulocyte colony-stimulating factor (G-CSF): a case report].
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Granulocyte Colony-Stimulating Factor; Humans; Lung Diseases, Fungal; Male; Methicillin Resistance; Miconazole; Pneumonia; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 1993 |
A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
Topics: Amphotericin B; Antifungal Agents; Burns; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Trichosporon; Yeasts | 1995 |
[A case of primary pulmonary cryptococcosis showing infiltrative shadows in the unilateral lung field].
Topics: Aged; Amphotericin B; Cryptococcosis; Fluconazole; Humans; Lung Diseases, Fungal; Male; Miconazole; Tomography, X-Ray Computed | 1994 |
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Blood; Cerebrospinal Fluid; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Skin | 1994 |
Risk factors for hepatosplenic abscesses in patients with acute leukemia receiving empiric azole treatment.
Topics: Abscess; Acute Disease; Adolescent; Adult; Aged; Candidiasis; Female; Fever; Fluconazole; Humans; Leukemia; Liver Abscess; Male; Miconazole; Middle Aged; Neutropenia; Opportunistic Infections; Recurrence; Retrospective Studies; Risk Factors; Splenic Diseases | 1994 |
Pneumocystis carinii is resistant to imidazole antifungal agents.
Topics: Animals; Antifungal Agents; Ergosterol; Female; Fluconazole; Gas Chromatography-Mass Spectrometry; Itraconazole; Ketoconazole; Miconazole; Pneumocystis; Rats; Rats, Sprague-Dawley; Triazoles | 1994 |
Notable clinical changes of hepatosplenic abscesses in febrile neutropenic patients receiving empiric antifungal treatment with azoles.
Topics: Abscess; Antifungal Agents; Candidiasis; Fever; Fluconazole; Humans; Leukemia; Liver Abscess; Lymphoma, Non-Hodgkin; Miconazole; Neutropenia; Spleen | 1994 |
[Clinical evaluation of diagnosis and treatment in three cases of primary pulmonary cryptococcosis].
Topics: Adult; Cryptococcosis; Female; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Male; Miconazole; Middle Aged; Radiography, Thoracic | 1993 |
[Two cases of early Acanthamoeba keratitis].
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Animals; Conjunctiva; Contact Lenses; Dexamethasone; Diagnosis, Differential; Female; Fluconazole; Humans; Male; Miconazole | 1993 |
[Vitreous surgery for mycotic endophthalmitis].
Topics: Aged; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Male; Miconazole; Middle Aged; Vitrectomy | 1993 |
Sch 39304, a new antifungal agent: oral and topical treatment of vaginal and superficial infections.
Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluconazole; Guinea Pigs; Miconazole; Tinea; Triazoles | 1993 |
Topical treatment of pulmonary aspergilloma by antifungals. Relationship between duration of the disease and efficacy of therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Aspergillus niger; Female; Fluconazole; Flucytosine; Humans; Instillation, Drug; Lung; Lung Diseases, Fungal; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Radiography; Time Factors; Treatment Outcome | 1993 |
Fungal mycotic aneurysms and visceral infection due to Scedosporium apiospermum in a kidney transplant patient.
Topics: Antitubercular Agents; Aortic Aneurysm, Abdominal; Candidiasis; Drug Therapy, Combination; Fluconazole; Gastrointestinal Hemorrhage; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Miconazole; Middle Aged; Mitosporic Fungi; Mycobacterium tuberculosis; Postoperative Complications; Tuberculosis | 1993 |
The effects of amphotericin B, fluconazole and miconazole on neutrophil and lymphocyte function in a guinea pig model.
Topics: Amphotericin B; Animals; Antifungal Agents; Chemotaxis, Leukocyte; Deoxyglucose; Female; Fluconazole; Guinea Pigs; Immunosuppression Therapy; Leukocyte Adherence Inhibition Test; Lymphocyte Activation; Lymphocytes; Miconazole; Neutrophils | 1995 |
Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.
Topics: Amphotericin B; Antifungal Agents; Antiviral Agents; Chromatography, High Pressure Liquid; Fluconazole; Flucytosine; Glucuronates; Humans; Itraconazole; Ketoconazole; Miconazole; Microsomes, Liver; Zidovudine | 1995 |
[Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Miconazole; Microbial Sensitivity Tests | 1996 |
In vitro susceptibility of Trichosporon beigelii to antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Miconazole; Microbial Sensitivity Tests; Trichosporon | 1996 |
Inhibition of mitochondrial function in isolated rate liver mitochondria by azole antifungals.
Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Fluconazole; In Vitro Techniques; Ketoconazole; Male; Miconazole; Mitochondria, Liver; Multienzyme Complexes; NADH, NADPH Oxidoreductases; Oxidative Phosphorylation; Rats; Succinate Dehydrogenase | 1996 |
[Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Drug Resistance, Microbial; Evaluation Studies as Topic; Fluconazole; Flucytosine; Indicator Dilution Techniques; Itraconazole; Miconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae | 1997 |
Rapid high performance liquid chromatographic assay for antifungal agents in human sera.
Topics: Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Spectrophotometry, Ultraviolet | 1996 |
[Evaluation of effective treatment drugs against Acanthamoeba cyst].
Topics: Acanthamoeba; Amphotericin B; Animals; Anti-Infective Agents, Local; Antifungal Agents; Antiprotozoal Agents; Cornea; Fluconazole; Humans; Keratitis; Miconazole; Natamycin; Pentamidine | 1997 |
Synergy of nitric oxide and azoles against Candida species in vitro.
Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Triazenes | 1998 |
Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Aspergillus; Drug Combinations; Drug Evaluation; Female; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Leukemia; Lymphoma; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Mouth Diseases; Neutropenia | 1999 |
Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitro.
Topics: Animals; Antifungal Agents; Azoles; Bone Marrow; Cells, Cultured; Clotrimazole; Dose-Response Relationship, Drug; Econazole; Female; Fluconazole; Granulocytes; Hematopoietic Stem Cells; Humans; Imidazoles; Inhibitory Concentration 50; Ketoconazole; Macrophages; Male; Mice; Miconazole; Species Specificity; Stem Cells | 1999 |
In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata.
Topics: Antifungal Agents; Azoles; Candida; Candidiasis; Clotrimazole; DNA, Fungal; DNA, Mitochondrial; Drug Resistance, Microbial; Econazole; Electrophoresis, Agar Gel; Fluconazole; Humans; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Polyenes | 1999 |
Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Reagent Kits, Diagnostic | 1999 |
Histamine release induced by antimicrobial agents and effects of antimicrobial agents on vancomycin-induced histamine release from rat peritoneal mast cells.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Cilastatin; Dose-Response Relationship, Drug; Fluconazole; Fosfomycin; Histamine Release; Male; Mast Cells; Miconazole; Peritoneal Cavity; Rats; Rats, Wistar; Vancomycin | 2000 |
Inhibitory effect of azole antifungal agents on the glucuronidation of lorazepam using rabbit liver microsomes in vitro.
Topics: Animals; Anti-Anxiety Agents; Antifungal Agents; Azoles; Binding, Competitive; Detergents; Fluconazole; Glucuronic Acid; In Vitro Techniques; Ketoconazole; Kinetics; Lorazepam; Male; Miconazole; Microsomes, Liver; Rabbits; Uridine Diphosphate Glucuronic Acid | 2000 |
Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 2000 |
In vitro susceptibility of Candida albicans isolates from apical and marginal periodontitis to common antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Fluconazole; Flucytosine; Humans; Miconazole; Microbial Sensitivity Tests; Periapical Periodontitis; Periodontitis | 2000 |
[Current problems in etiotropic therapy of mycoses].
Topics: Amphotericin B; Antifungal Agents; Candicidin; Candida; Fluconazole; Humans; Itraconazole; Miconazole; Mycoses; Nystatin | 2001 |
Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia.
Topics: Acute Disease; Aged; Aged, 80 and over; Antifungal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Division; Clone Cells; Female; Fluconazole; Humans; Interferon-gamma; Interleukin-4; Itraconazole; Ketoconazole; Leukemia, Myeloid; Leukopenia; Lymphocyte Activation; Male; Miconazole; Middle Aged; Neoplastic Stem Cells; T-Lymphocytes | 2001 |
Use of cisapride with contraindicated drugs in The Netherlands.
Topics: Cisapride; Clarithromycin; Contraindications; Databases, Factual; Drug Interactions; Drug Labeling; Drug Prescriptions; Fluconazole; Follow-Up Studies; Humans; Miconazole; Netherlands; Retrospective Studies | 2002 |
Antifungal drug susceptibilities of commensal Candida isolates.
Topics: Antifungal Agents; Candida; Child; Dental Plaque; Ecosystem; Female; Fluconazole; Humans; Male; Miconazole; Microbial Sensitivity Tests; Mouth Mucosa; Nonprescription Drugs; Saliva | 2002 |
Colonization of voice prostheses by albicans and non-albicans Candida species.
Topics: Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Larynx, Artificial; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Prevalence; Prosthesis-Related Infections | 2002 |
Pathogenic Nocardia, Rhodococcus, and related organisms are highly susceptible to imidazole antifungals.
Topics: Antifungal Agents; Clotrimazole; Fluconazole; Imidazoles; Miconazole; Microbial Sensitivity Tests; Nocardia; Rhodococcus | 2003 |
Antifungal activity of amiodarone is mediated by disruption of calcium homeostasis.
Topics: Amiodarone; Antifungal Agents; Calcineurin; Calcium; Calcium Channels; Calcium-Binding Proteins; Calcium-Transporting ATPases; Drug Synergism; Fluconazole; Gene Deletion; Homeostasis; Miconazole; Molecular Chaperones; Mutation; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; TRPC Cation Channels | 2003 |
Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
Topics: Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Rhodotorula | 2003 |
Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
Topics: Antifungal Agents; Biofilms; Candida albicans; Chlorhexidine; Colony Count, Microbial; Disinfectants; Fermentation; Fluconazole; Longitudinal Studies; Miconazole; Microbial Sensitivity Tests | 2004 |
New beauvericins, potentiators of antifungal miconazole activity, Produced by Beauveria sp. FKI-1366. I. Taxonomy, fermentation, isolation and biological properties.
Topics: Antifungal Agents; Ascomycota; Candida albicans; Chromatography, High Pressure Liquid; Depsipeptides; Drug Resistance, Fungal; Drug Synergism; Fermentation; Fluconazole; Macrolides; Miconazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning | 2004 |
Patterns of antifungal prescribing in general dental practice.
Topics: Age Factors; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Drug Prescriptions; Fluconazole; General Practice, Dental; Humans; Miconazole; Nystatin; Practice Patterns, Dentists'; Surveys and Questionnaires; United Kingdom | 2004 |
In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
Topics: Antifungal Agents; Arthrodermataceae; Ascomycota; Clotrimazole; Econazole; Fluconazole; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Terbinafine; Thiophenes | 2004 |
DNA identification of the pathogen of candidal aspiration pneumonia induced in the course of oral cancer therapy.
Topics: Aerosols; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Base Sequence; Candida albicans; Candidiasis; Candidiasis, Oral; Carcinoma, Squamous Cell; DNA, Fungal; Fatal Outcome; Female; Fluconazole; Humans; Miconazole; Mouth Neoplasms; Pneumonia, Aspiration; Random Amplified Polymorphic DNA Technique | 2005 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2005 |
Modification of the fluorescein diacetate assay for screening of antifungal agents against Candida albicans: comparison with the NCCLS methods.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Culture Media; Fluconazole; Flucytosine; Fluoresceins; Fluorometry; Miconazole; Microbial Sensitivity Tests | 2006 |
[Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Japan; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Minimally Invasive Surgical Procedures; Peptides, Cyclic | 2005 |
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Species Specificity | 2006 |
The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Chemoprevention; Chronic Disease; Cohort Studies; Comprehensive Health Care; Female; Fluconazole; Follow-Up Studies; Heterosexuality; Humans; Itraconazole; Male; Miconazole; Middle Aged; Nystatin; Population Surveillance; Retrospective Studies; South Africa; Treatment Outcome | 1999 |
The postantifungal effect (PAFE) of itraconazole, in comparison with those of miconazole and fluconazole, on Candida Species.
Topics: Antifungal Agents; Candida; Candida albicans; Fluconazole; Itraconazole; Miconazole; Microbial Sensitivity Tests; Time Factors | 2006 |
Successful treatment of Paecilomyces lilacinus keratitis in a patient with a history of herpes simplex virus keratitis.
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Cornea; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Humans; Keratitis, Herpetic; Keratoplasty, Penetrating; Male; Miconazole; Middle Aged; Mycoses; Paecilomyces; Reoperation; Retrospective Studies | 2006 |
Synthesis, antifungal activity, and structure-activity relationships of coruscanone A analogues.
Topics: Animals; Antifungal Agents; Candida albicans; Cell Survival; Chlorocebus aethiops; Cryptococcus neoformans; Cyclopentanes; Drug Resistance, Fungal; Fluconazole; LLC-PK1 Cells; Miconazole; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Swine; Vero Cells | 2006 |
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyridones; Terbinafine | 2007 |
Use of isolated hepatocyte preparations for cytochrome P450 inhibition studies: comparison with microsomes for Ki determination.
Topics: Animals; Catalysis; Cells, Cultured; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dextromethorphan; Enzyme Inhibitors; Fluconazole; Fluoxetine; Fluvoxamine; Hepatocytes; Ketoconazole; Kinetics; Male; Miconazole; Microsomes, Liver; Midazolam; Phenytoin; Quinine; Rats; Rats, Sprague-Dawley; Tolbutamide | 2007 |
Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole.
Topics: Antifungal Agents; Candida albicans; Drug Administration Schedule; Drug Resistance, Fungal; Fluconazole; Humans; Ketoconazole; Miconazole; Polyendocrinopathies, Autoimmune | 2008 |
The amino acid residues of transmembrane helix 5 of multidrug resistance protein CaCdr1p of Candida albicans are involved in substrate specificity and drug transport.
Topics: Adenosine Triphosphatases; Amino Acid Sequence; Azides; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Membrane Transport Proteins; Miconazole; Mutagenesis, Site-Directed; Prazosin; Protein Transport; Rhodamines; Saccharomyces cerevisiae; Substrate Specificity | 2009 |
Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals.
Topics: Anisomycin; Antifungal Agents; Biological Transport; Candida albicans; Curcumin; Cycloheximide; Drug Synergism; Enzyme Inhibitors; Fluconazole; Itraconazole; Ketoconazole; Methotrexate; Miconazole; Multidrug Resistance-Associated Proteins; Pyrimidines; Rhodamines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2009 |
Antifungal activity of miconazole against recent Candida strains.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Miconazole; Microbial Sensitivity Tests | 2010 |
Screening of antimycotics in Swedish sewage treatment plants--waters and sludge.
Topics: Antifungal Agents; Clotrimazole; Econazole; Environmental Monitoring; Fluconazole; Ketoconazole; Miconazole; Naphthalenes; Sewage; Sweden; Terbinafine; Waste Disposal, Fluid; Water Pollutants, Chemical | 2010 |
Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).
Topics: Antifungal Agents; Azoles; Candida albicans; Econazole; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Protein Binding; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2010 |
Ketoconazole and miconazole alter potassium homeostasis in Saccharomyces cerevisiae.
Topics: Antifungal Agents; Cations; Fluconazole; Glucose; Glucosephosphate Dehydrogenase; Homeostasis; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Miconazole; Nucleotides; Oxygen Consumption; Potassium; Protons; Saccharomyces cerevisiae | 2011 |
Microarray-based target identification using drug hypersensitive fission yeast expressing ORFeome.
Topics: Antifungal Agents; Antineoplastic Agents, Phytogenic; Brefeldin A; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Etoposide; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genome, Fungal; Miconazole; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Open Reading Frames; Schizosaccharomyces; Xenobiotics | 2011 |
The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Apoptosis; ATP-Binding Cassette Transporters; Biological Transport, Active; Candida albicans; Drug Resistance, Multiple, Fungal; Drug Synergism; Farnesol; Fluconazole; Fungal Proteins; Ketoconazole; Kinetics; Membrane Transport Proteins; Miconazole; Microbial Sensitivity Tests; Quorum Sensing; Reactive Oxygen Species; Rhodamines; Saccharomyces cerevisiae | 2011 |
In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Miconazole; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Is elevation of the serum β-d-glucan level a paradoxical sign for trichosporon fungemia in patients with hematologic disorders?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; beta-Glucans; Echinocandins; Female; Fluconazole; Fungemia; Hematologic Diseases; Humans; Immunocompromised Host; Lipopeptides; Male; Micafungin; Miconazole; Middle Aged; Proteoglycans; Retrospective Studies; Treatment Outcome; Trichosporon; Young Adult | 2012 |
Distribution, behavior and fate of azole antifungals during mechanical, biological, and chemical treatments in sewage treatment plants in China.
Topics: Antifungal Agents; Azoles; Biodegradation, Environmental; China; Clotrimazole; Econazole; Environmental Monitoring; Fluconazole; Ketoconazole; Miconazole; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical | 2012 |
[Fungi isolated from the vagina and their susceptibility to antifungals].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Miconazole; Microbial Sensitivity Tests; Middle Aged; Poland; Retrospective Studies; Vagina; Young Adult | 2012 |
Effective microPET imaging of brain 5-HT(1A) receptors in rats with [(18) F]MeFWAY by suppression of radioligand defluorination.
Topics: Animals; Brain; Brain Chemistry; Drug Stability; Fluconazole; Fluorine Radioisotopes; Ligands; Male; Miconazole; Piperazines; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT1 | 2012 |
In vitro antifungal activity of two tissue conditioners combined with nystatin, miconazole and fluconazole against Candida albicans.
Topics: Antifungal Agents; Candida albicans; Colony Count, Microbial; Denture Bases; Denture Liners; Fluconazole; Humans; Materials Testing; Methacrylates; Methylmethacrylates; Miconazole; Microbial Sensitivity Tests; Microbial Viability; Nystatin; Phthalic Acids; Tissue Conditioning, Dental | 2012 |
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Trichophyton mentagrophytes cause underestimated contagious zoophilic fungal infection.
Topics: Administration, Oral; Administration, Topical; Adult; Animals; Anti-Inflammatory Agents; Antifungal Agents; Child; Child, Preschool; Diflucortolone; Environmental Exposure; Family Health; Female; Fluconazole; Humans; Male; Miconazole; Naphthalenes; Pets; Terbinafine; Tinea; Treatment Outcome; Trichophyton | 2013 |
Potentiation of azole antifungals by 2-adamantanamine.
Topics: Amantadine; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis, Cutaneous; Culture Media; Drug Evaluation, Preclinical; Drug Synergism; Ergosterol; Fluconazole; Gene Expression Profiling; Guinea Pigs; Hep G2 Cells; Hepatocytes; Humans; Miconazole | 2013 |
Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Conjunctiva; Eurotium; Female; Fluconazole; Fungi; Horses; Itraconazole; Male; Miconazole; Microbial Sensitivity Tests; Switzerland; Voriconazole | 2014 |
In vitro anti-Candida activity of certain new 3-(1H-imidazol-1-yl)propan-1-one oxime esters.
Topics: Antifungal Agents; Candida albicans; Candida tropicalis; Esters; Fluconazole; Imidazoles; Miconazole; Microbial Sensitivity Tests; Oximes | 2013 |
Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Autoimmune Diseases; Bacterial Load; Candida; Candida albicans; Candida glabrata; Candidiasis, Oral; Coinfection; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Miconazole; Microbial Sensitivity Tests; Middle Aged; Xerostomia | 2014 |
Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Miconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Nystatin; Retrospective Studies | 2015 |
Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Artemisinins; Artesunate; Biofilms; Candida albicans; Candidiasis; Caspofungin; Drug Synergism; Echinocandins; Fluconazole; Hexachlorophene; Lipopeptides; Miconazole; Microbial Sensitivity Tests; Pyrvinium Compounds; Reactive Oxygen Species | 2015 |
Molecularly imprinted solid phase extraction of fluconazole from pharmaceutical formulations.
Topics: Acetonitriles; Fluconazole; Imidazoles; Methacrylates; Metronidazole; Miconazole; Molecular Imprinting; Polymers; Solid Phase Extraction | 2015 |
The role of antifungal and antiviral agents in primary dental care.
Topics: Acyclovir; Amphotericin B; Antifungal Agents; Antiviral Agents; Candidiasis, Oral; Cheilitis; Dental Care; Fluconazole; Glossitis; Guanine; Herpes Zoster; Humans; Miconazole; Mouth Diseases; Nystatin; Primary Health Care; Stomatitis, Herpetic | 2014 |
Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan.
Topics: Administration, Topical; Adult; Aged; Amphotericin B; Antifungal Agents; Attitude of Health Personnel; Candidiasis, Oral; Cross-Sectional Studies; Drug Prescriptions; Female; Fluconazole; Humans; Jordan; Male; Miconazole; Middle Aged; Nystatin; Practice Patterns, Dentists'; Private Practice; Professional Practice; Public Health Dentistry; Referral and Consultation; Sex Factors; Workplace | 2015 |
Crowded growth leads to the spontaneous evolution of semistable coexistence in laboratory yeast populations.
Topics: Algorithms; Antifungal Agents; Biodiversity; Biological Evolution; Ecosystem; Environment; Fluconazole; Miconazole; Models, Biological; Population Density; Population Dynamics; Saccharomyces cerevisiae; Time-Lapse Imaging | 2015 |
Synergistic effects of tea catechin epigallocatechin gallate and antimycotics against oral Candida species.
Topics: Amphotericin B; Anilides; Antifungal Agents; Biofilms; Candida; Catechin; Drug Synergism; Fluconazole; Miconazole; Microbial Sensitivity Tests; Polyphenols; Tetrazolium Salts | 2015 |
Stepwise design, synthesis, and in vitro antifungal screening of (Z)-substituted-propenoic acid derivatives with potent broad-spectrum antifungal activity.
Topics: 14-alpha Demethylase Inhibitors; Acrylates; Amino Acid Sequence; Antifungal Agents; Binding Sites; Drug Design; Fluconazole; Miconazole; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Sequence Data; Protein Binding; Protein Conformation; Sterol 14-Demethylase; Structure-Activity Relationship | 2015 |
Vba4p, a vacuolar membrane protein, is involved in the drug resistance and vacuolar morphology of Saccharomyces cerevisiae.
Topics: Amino Acid Transport Systems, Basic; Amino Acids; Antifungal Agents; Biological Transport; Drug Resistance, Fungal; Fluconazole; Gene Expression; Intracellular Membranes; Ketoconazole; Miconazole; Organelle Shape; Protein Isoforms; Protein Structure, Secondary; Protein Structure, Tertiary; Saccharomyces cerevisiae; Salt Tolerance; Sodium Chloride; Vacuoles | 2016 |
Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; China; Clotrimazole; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Miconazole; Microbial Sensitivity Tests | 2016 |
Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies.
Topics: Agar; Amphotericin B; Antifungal Agents; Culture Media; Fluconazole; Itraconazole; Malassezia; Miconazole; Microbial Sensitivity Tests; Voriconazole | 2017 |
Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans.
Topics: Agar; Amino Acid Sequence; Antifungal Agents; Antimicrobial Cationic Peptides; Candida albicans; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Miconazole; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship | 2017 |
Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal.
Topics: Antifungal Agents; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Clotrimazole; Cross-Sectional Studies; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Miconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Nepal; Severity of Illness Index; Tertiary Care Centers | 2017 |
Comparative Molecular Dynamics Simulation of Aggregating and Non-Aggregating Inhibitor Solutions: Understanding the Molecular Basis of Promiscuity.
Topics: Colloids; Drug Design; Drug Discovery; Enzyme Inhibitors; Enzymes; False Positive Reactions; Fluconazole; Hydrophobic and Hydrophilic Interactions; Micelles; Miconazole; Molecular Dynamics Simulation; Molecular Structure; Solutions; Substrate Specificity | 2018 |
Population Impact of Drug Interactions with Warfarin: A Real-World Data Approach.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anticoagulants; Carbamazepine; Databases, Factual; Drug Interactions; Female; Fluconazole; Follow-Up Studies; Humans; International Normalized Ratio; Male; Miconazole; Middle Aged; Nystatin; Primary Health Care; Retrospective Studies; United Kingdom; Warfarin; Young Adult | 2018 |
Reduced Antifungal Susceptibility of Vulvovaginal Candida Species at Normal Vaginal pH Levels: Clinical Implications.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Miconazole; Microbial Sensitivity Tests; Retrospective Studies | 2018 |
In vitro combination of antifungal agents against Malassezia pachydermatis.
Topics: Antifungal Agents; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Itraconazole; Malassezia; Miconazole; Microbial Sensitivity Tests | 2019 |
The classic azole antifungal drugs are highly potent endocrine disruptors in vitro inhibiting steroidogenic CYP enzymes at concentrations lower than therapeutic Cmax.
Topics: Antifungal Agents; Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Clotrimazole; Dose-Response Relationship, Drug; Endocrine Disruptors; Fluconazole; Gas Chromatography-Mass Spectrometry; Humans; Inhibitory Concentration 50; Ketoconazole; Miconazole; Steroid 17-alpha-Hydroxylase | 2019 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |
Antimycotic Treatment of Oral Candidiasis in Warfarin Users.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antifungal Agents; Candidiasis, Oral; Drug Interactions; Female; Fluconazole; Gels; Humans; International Normalized Ratio; Male; Miconazole; Solutions; Warfarin | 2021 |
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole | 2022 |
New miconazole-based azoles derived from eugenol show activity against Candida spp. and Cryptococcus gattii by inhibiting the fungal ergosterol biosynthesis.
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Cryptococcus gattii; Ergosterol; Eugenol; Fluconazole; Imidazoles; Miconazole; Microbial Sensitivity Tests | 2023 |
Efficacy of manuka honey with conventional antifungals on
Topics: Animals; Antifungal Agents; Azoles; Cat Diseases; Cats; Clotrimazole; Dog Diseases; Dogs; Fluconazole; Honey; Itraconazole; Miconazole | 2023 |